Life360 Innovations Inc.’s (Life360 Innovations) network of Contino® Authorised Clinics has expanded to include Ladner Village Physiotherapy in Ladner, BC and PG Pelvic Floor and Core Rehabilitation Centre in Prince George, BC. Men with urinary incontinence (UI) can now book an independent assessment at these locations, as well as the Dayan Physiotherapy and Pelvic Floor Clinic in Vancouver, BC, to determine whether Contino® is right for them.
As part of this expansion, we welcome Nicole Coffey and Wendy Marchlewitz as Contino® Authorised Trainers. Contino® Authorised Trainers are experienced incontinence specialists who have been trained to perform an independent assessment of whether Contino® is right for clients and, if so, conduct a personalised fitting and provide training on how to use the product.
Nicole and Wendy are Registered Physiotherapists with extensive experience treating UI in men. Nicole is a lifetime Ladner resident who has served the South Delta community as a physiotherapist since 2011, with a special interest in incontinence. Wendy has practiced in Canada for over 15 years and has opened the first BC based physiotherapy clinic outside of the Lower Mainland that specializes in pelvic floor and incontinence.
“I think patients are looking for an alternative to the existing treatments and products, say Nicole, the Contino® is an innovative solution we are excited to offer.”
“Our clinic looks forward to providing another product for men suffering from UI, which can be a distressing and chronic condition, says Wendy, adding that I think it will be a welcomed alternative for some of my patients”.
“Nicole Coffey and Wendy Marchlewitz are experienced incontinence specialists who we know will provide outstanding support to Contino® clients in the Delta/Surrey and Central/Northern BC regions” says Robert Orr, President & CEO of Life360 Innovations. “They have dedicated incontinence practices with years of experience in their respective communities, making them a welcome addition to the Contino® Authorised Clinic network.”
Contino® is a self-administered licensed medical device that controls bladder leakage in men. Much more than just a device, Contino® is an integrated solution that includes personalised fitting and support from incontinence specialists, so men can get on with life.
Robert Orr, President & CEO
Toll-free North America: +1-833-543-3311
About Life360 Innovations Inc.
Life360 Innovations imagines, manufactures and distributes Health Canada Licensed medical devices under the Contino® brand. For more information on Life360 Innovations, visit life360innovations.com.
Cautionary Disclaimer Regarding Forward-Looking Statements and Information
This news release contains certain forward-looking statements concerning Life360 Innovations Holdings Inc. and its’ wholly owned subsidiaries (collectively, the “Companies”) in future periods. Statements that are not historical fact are “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995 and “forward looking information” as that term is defined in National Instrument 51-102 (“NI 51-102”) of the Canadian Securities Administrators (collectively, “forward-looking statements”). This document contains certain forward-looking statements relating, but not limited to, the Company’s expectations, intentions, plans and beliefs. Forward-looking information can often be identified by forward-looking words such as “anticipate”, “believe”, “expect”, “goal”, “plan”, “intend”, “estimate”, “may”, and “will”, or similar words suggesting future outcomes, or other expectations, beliefs, plans, objectives, assumptions, intentions, or statements about future events or performance. Forward-looking information may include estimates of future operations, sales, unit costs, costs of capital projects and the timing of commencement of operations that are based on current expectations that involve a number of business risks and uncertainties.
Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to, failure to establish estimated revenues, capital and operating costs varying significantly from estimates, delays in obtaining or failures to obtain required regulatory approvals, inflation, changes in exchange rates, delays in the development of projects and other factors. Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from expected results.
Shareholders and prospective investors should be aware that these forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. Shareholders are cautioned not to place undue reliance on forward-looking information. By its nature, forward-looking information involves numerous assumptions, inherent risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and various assumed future events will not occur. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking information whether as a result of new information, future events, or other such factors that affect this information, except as required by law.